SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED Financials
- Company number
- 02950518CopyCopy
- Registered office
- 82 St John Street, London EC1M 4JN
- Incorporated
- 14/07/1994
Company snapshot
- Status
- Active
- Employees
- 0 (2025)
- Latest financial data
- 2025
- Accounts type
- Total Exemption Full
Financial highlights
Latest reported figures. Okredo holds filed data for 2021–2025.
Net Assets
-2.30%vs 20242024: £6.92M
Total Assets
1.80%vs 20242024: £8.18M
Cash in Bank
-38.34%vs 20242024: £855.42K
Total Liabilities
25.73%vs 20242024: £1.20M
Employees
0vs 20242024: 0
In 2025, SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED reported net assets of £6.76M. The same filing shows total assets of £8.33M, cash in bank of £527.44K and total liabilities of £1.51M. Reported headcount was 0 in 2025. Cash in Bank fell from £855.42K in 2024 to £527.44K in 2025 (-38.34%). Okredo holds filed figures for 2021–2025; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
-2.30%from £6.92M in 2024Year-on-year change
Net Assets as filed for 2021–2025. Every figure in this chart is also in the financial history table.
3-year financial trend (2023–2025)
How the figures SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.
Net Assets
+0.5%vs 2023+0.3% a year compound (CAGR)
Cash in Bank
-37.9%vs 2023-21.2% a year compound (CAGR)
Total Assets
+4.9%vs 2023+2.4% a year compound (CAGR)
Total Liabilities
+24.6%vs 2023+11.6% a year compound (CAGR)
Employees
-100%vs 2023-12Biggest increase
Total Liabilities+24.6%
£1.21M in 2023 to £1.51M in 2025
Biggest decrease
Employees-100%
12 in 2023 to 0 in 2025
SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED's filings pull in both directions between 2023 and 2025. The steepest rise came in total liabilities, pointing to heavier outstanding obligations, set against a fall in employee numbers, pointing to a smaller workforce. See the full year-by-year figures.
Ratios from the filed figures
Calculated from SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- 81.20%2025
- Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
- Liabilities to total assets
- 18.13%2025
- Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
- Cash to liabilities
- 34.93%2025
- Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
- Cash to total assets
- 6.33%2025
- Reported cash in bank divided by reported total assets, for the latest year both were filed.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Assets£ | 4.86M | 6.28M | 6.73M | 6.92M | 6.76M |
| Total Assets£ | 6.38M | – | 7.94M | 8.18M | 8.33M |
| Cash in Bank£ | 450.73K | 720.90K | 849.03K | 855.42K | 527.44K |
| Total Liabilities£ | 1.52M | – | 1.21M | 1.20M | 1.51M |
| Employees | 17 | 13 | 12 | 0 | 0 |
SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED financials: frequently asked questions
Answered from this company's own filed figures.
Yes. Okredo holds filed figures for SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED covering 2021–2025, across 5 reported indicators. The most recent reported year is 2025.
SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED reported net assets of £6.76M for 2025. That compares with £6.92M in 2024, a change of -2.30%.
SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED reported total assets of £8.33M for 2025. That compares with £8.18M in 2024, a change of 1.80%.
SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED reported cash in bank of £527.44K for 2025. That compares with £855.42K in 2024, a change of -38.34%.
SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED reported 0 employees in 2025, compared with 0 in 2024.
Between 2023 and 2025, SYNER-MED (PHARMACEUTICAL PRODUCTS) LIMITED's net assets rose by 0.5%, cash in bank fell by 37.9%, total assets rose by 4.9% and total liabilities rose by 24.6%. Net assets compounded at 0.3% a year across the two years to 2025, from £6.73M to £6.76M. Reported headcount went from 12 in 2023 to 0 in 2025 (-12).
Okredo holds reported figures for the years 2021, 2022, 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.